To further address these questions, our ongoing studies integrate single-cell and bulk transcriptomic analyses, coupled with detailed characterization of TPM2 across tumor compartments, aiming to elucidate its context-dependent role in CRC progression and metastasis. The gene discussed is TPM2; the disease is neoplasm.